Related Experiment Video
Updated: Feb 6, 2026

Orthotopic Implantation of Patient-Derived Cancer Cells in Mice Recapitulates Advanced Colorectal Cancer
Published on: February 10, 2023
Aurovertin B sensitizes colorectal cancer cells to NK cell recognition and lysis
Huifang Zhu1, Fei Wang2, Xiaoman Ju1
1State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming, 650201, PR China; University of Chinese Academy of Sciences, Beijing, PR China.
Abstract:
The natural killer group 2D (NKG2D) receptor on natural killer (NK) cells play an important role in immunosurveillance to cancer cells, which could mediate the eradication of tumor cells through specific interactions with NKG2D ligands on tumor cells. Here we report one natural compound aurovertin B from basidiomycete Albatrellus confluens significantly stimulates the expression of NKG2D ligands on tumor cells, which greatly sensitizes its recognition and lysis by NK cell. It is completely a novel role for aurovertin B to target tumor cells to death mediated by NK cells and our findings indicate aurovertin B may deserve further development as sensitizing agent in NK cell mediated cancer immunotherapy.
Insights
Aurovertin B, a natural compound, enhances cancer cell recognition and destruction by natural killer (NK) cells. This compound boosts NKG2D ligand expression on tumor cells, making them more susceptible to NK cell-mediated killing, suggesting its potential in cancer immunotherapy.
Area of Science:
- Immunology
- Natural Products Chemistry
- Cancer Research
Background:
- Natural killer (NK) cells are crucial for immunosurveillance against cancer.
- The NKG2D receptor on NK cells mediates tumor cell recognition and lysis via interactions with NKG2D ligands on cancer cells.
Purpose of the Study:
- To investigate the effect of the natural compound aurovertin B on NK cell-mediated cancer cell cytotoxicity.
- To explore a novel role for aurovertin B in cancer immunotherapy.
Main Methods:
- Treatment of tumor cells with aurovertin B.
- Assessment of NKG2D ligand expression on tumor cells.
- Evaluation of NK cell-mediated tumor cell recognition and lysis.
Main Results:
- Aurovertin B significantly stimulates the expression of NKG2D ligands on tumor cells.
- This stimulation enhances the recognition and lysis of tumor cells by NK cells.
- Aurovertin B demonstrates a novel mechanism for targeting tumor cells for NK cell-mediated destruction.
Conclusions:
- Aurovertin B acts as a sensitizing agent, improving NK cell-mediated cancer cell killing.
- Aurovertin B holds promise for further development as an adjuvant therapy in NK cell-based cancer immunotherapy.
More Related Videos
Related Concept Videos
Tissue Homogenization and Cell Lysis
Mechanical methods of tissue homogenization
These methods rely on applying external physical force to disrupt...
Immune Surveillance by NK Cells and Phagocytes
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Cancer Cell Migration through Invadopodia
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Distinctive Features of Adult Stem Cells vs Cancer Stem Cells
Adult stem cells
Adult stem cells are tissue-specific; hence, they divide to develop the tissue from which they originate. One type of adult stem cell is the epithelial stem cell, which gives rise to the keratinocytes in the multiple layers of epithelial cells in the epidermis of the skin. Adult bone marrow has three distinct types of stem cells:...

